September 22nd - 24th, 2014
St. Julien Hotel & Spa
Boulder, CO
USA

PEPTIDE THERAPEUTICS FOR INFECTIOUS DISEASE
The 2014 Boulder Peptide Symposium once again brings together thought leaders in biotech, pharma, and academic institutions to present current paradigms in combating infectious diseases and to uncover solutions to challenges in peptide drug discovery and development. The symposium will address the key requirements for development of effective anti-infective peptide therapeutics including novel delivery mechanisms for difficult to reach infectious loci, and the need for low-cost drugs. Key opinion leaders will discuss case studies and progress made with peptides in solving major healthcare issues such as drug resistant bacterial strains (MRSA), the viral threat of HIV, HCV, and pandemic flu, and neglected disease areas including tropical diseases like malaria. The symposium will also explore the use of novel synthetic peptide chemistry to create highly constrained stapled and cyclic structures. Such modifications can provide important functional enhancements such as improvements in oral delivery, cell penetration, and formulation stability.

ABOUT THE BOULDER PEPTIDE SYMPOSIUM
The Boulder Peptide Symposium seeks to bring together key decision leaders from both industry and academia to discuss the future of peptide therapeutics. Peptide therapeutics are potent and highly selective yet their development into effective treatments can be challenged by limited delivery routes, product stability, manufacturing challenges and an evolving regulatory landscape. BPS is the key forum where these challenges will be identified, discussed, and one day—addressed.

Iris Biotech will be present on Boulder Peptide Symposium 2014 as an official sponsor and we are looking forward to meet you there at our booth.